{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:05Z","timestamp":1788514685965,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","award":["UL1TR004419"],"award-info":[{"award-number":["UL1TR004419"]}],"id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.01.082","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:54:54Z","timestamp":1738407294000},"page":"1277-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis"],"prefix":"10.1016","volume":"92","author":[{"given":"Benjamin","family":"Ungar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digpal","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panipak","family":"Temboonnark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragasruti","family":"Metukuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Correa Da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Gay-Mimbrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"G\u00f3mez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Shemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.14091","article-title":"An update on the microbiology, immunology and genetics of seborrheic dermatitis","volume":"29","author":"Adalsteinsson","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2025.01.082_bib2","series-title":"Fitzpatrick\u2019s Color Atlas and Synopsis of Clinical Dermatology","first-page":"48","author":"Saavedra","year":"2023"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.082_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2340\/00015555-1731","article-title":"Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex","volume":"94","author":"Sampogna","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2022.12.017","article-title":"Unmet needs for patients with seborrheic dermatitis","volume":"90","author":"Jackson","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.01.082_bib6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2147\/CCID.S284671","article-title":"An overview of the diagnosis and management of seborrheic dermatitis","volume":"15","author":"Dall'Oglio","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.082_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00128071-200405060-00006","article-title":"Role of antifungal agents in the treatment of seborrheic dermatitis","volume":"5","author":"Gupta","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.01.082_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/exd.14006","article-title":"Seborrheic dermatitis-looking beyond Malassezia","volume":"28","author":"Wikramanayake","year":"2019","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2133.2001.04082.x","article-title":"Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry","volume":"144","author":"Faergemann","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1521-6616(03)00003-2","article-title":"Up-regulated expression of MICA and proinflammatory cytokines in skin biopsies from patients with seborrhoeic dermatitis","volume":"106","author":"Molinero","year":"2003","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1361573","article-title":"Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial","volume":"9","author":"Kamamoto","year":"2017","journal-title":"Dermatoendocrinol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jaad.2023.12.065","article-title":"Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: a randomized, double-blinded, vehicle-controlled, phase 3 trial","volume":"90","author":"Blauvelt","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.082_bib15","article-title":"Apremilast reduces IL-17F, IL-17A, IL-22, and TNF-a plasma protein levels in patients with moderate to severe plaque psoriasis: pharmacodynamic and correlative results from phase 2\/3 studies [abstract]","volume":"76","author":"Krueger","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.01.082_bib16","first-page":"835","article-title":"Mechanisms underlying the clinical effects of apremilast for psoriasis","volume":"17","author":"Pincelli","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaad.2023.02.064","article-title":"Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin","volume":"89","author":"Kim","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/exd.13808","article-title":"The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition","volume":"28","author":"Guttman-Yassky","year":"2019","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.116.232819","article-title":"Treatment of skin inflammation with benzoxaborole phosphodiesterase inhibitors: selectivity, cellular activity, and effect on cytokines associated with skin inflammation and skin architecture changes","volume":"358","author":"Dong","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.082_bib20","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00403-023-02680-9","article-title":"IL-12\/23-targeting in seborrheic dermatitis patients leads to long-lasting response","volume":"315","author":"Ghalili","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2025.01.082_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","article-title":"Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis","volume":"147","author":"He","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.082_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaci.2017.10.046","article-title":"Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype","volume":"141","author":"Dyjack","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2025.01.082_bib23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2019.03.1160","article-title":"Side-by-side comparison of skin biopsies and skin tape stripping highlights abnormal stratum corneum in atopic dermatitis","volume":"139","author":"Kim","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2018.04.031","article-title":"Detection of IL-36gamma through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema","volume":"142","author":"Berekmeri","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/all.15845","article-title":"Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies","volume":"79","author":"Del Duca","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/all.14490","article-title":"Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin","volume":"76","author":"Pavel","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2025.01.082_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2023.11.048","article-title":"Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa","volume":"90","author":"Navrazhina","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.01.082_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ Screen: a tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Res"},{"issue":"19","key":"10.1016\/j.jaad.2025.01.082_bib29","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.082_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib32","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.082_bib33","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaad.2025.01.082_bib34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.12688\/f1000research.9005.1","article-title":"RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR","volume":"5","author":"Law","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.jaad.2025.01.082_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response","volume":"134","author":"Dhingra","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib40","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.01.082_bib41","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jid.2022.03.022","article-title":"Transcriptomic analysis of the major orphan ichthyosis subtypes reveals shared immune and barrier signatures","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","article-title":"Ichthyosis molecular fingerprinting shows profound T(H)17 skewing and a unique barrier genomic signature","volume":"143","author":"Malik","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2025.01.082_bib43","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/jid.2014.28","article-title":"Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms","volume":"134","author":"Li","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaci.2014.10.037","article-title":"Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection","volume":"135","author":"Esaki","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.01.082_bib45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.01.082_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jid.2023.02.015","article-title":"Gene expression-based molecular test as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin-fixed and paraffin-embedded tissue, microbiopsies, and tape strips","volume":"143","author":"Fischer","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anai.2023.11.020","article-title":"Diversity of atopic dermatitis and selection of immune targets","volume":"132","author":"Rothenberg-Lausell","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"10.1016\/j.jaad.2025.01.082_bib49","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.3390\/ijms21207488","article-title":"New treatment addressing the pathogenesis of psoriasis","volume":"21","author":"Tokuyama","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jaad.2025.01.082_bib50","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/exd.13798","article-title":"Increased IL-17-expressing \u03b3\u03b4 T cells in seborrhoeic dermatitis-like lesions of the Mpzl3 knockout mice","volume":"27","author":"Wikramanayake","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2025.01.082_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1029818","article-title":"Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations","volume":"13","author":"Zouboulis","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/QCO.0b013e328342f787","article-title":"Malassezia virulence determinants","volume":"24","author":"Hort","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13693780802314825","article-title":"The lipolytic enzymes activities of Malassezia species","volume":"47","author":"Juntachai","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaad.2025.01.082_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biochi.2023.09.023","article-title":"A Malassezia pseudoprotease dominates the secreted hydrolase landscape and is a potential allergen on skin","volume":"216","author":"Chua","year":"2024","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib55","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.15879","article-title":"Sebocytes contribute to skin inflammation by promoting the differentiation of T helper 17 cells","volume":"178","author":"Mattii","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.082_bib56","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.1800893","article-title":"Short-chain fatty acids from Cutibacterium acnes activate both a canonical and epigenetic inflammatory response in human sebocytes","volume":"202","author":"Sanford","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2025.01.082_bib57","author":"Tucker"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-1293.2004.00185.x","article-title":"Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy","volume":"5","author":"Dunic","year":"2004","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1468-3083.2009.03470.x","article-title":"Seborrheic dermatitis among Oxford renal transplant recipients","volume":"24","author":"Lally","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/ctr.12215","article-title":"Mucocutaneous disorders in renal transplant recipients receiving sirolimus-based immunosuppressive therapy: a prospective, case-control study","volume":"27","author":"\u00d6zcan","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaad.2025.01.082_bib61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fneur.2019.00758","article-title":"Malassezia and Parkinson's disease","volume":"10","author":"Laurence","year":"2019","journal-title":"Front Neurol"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.082_bib62","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1365-4362.1997.00309.x","article-title":"Anti-inflammatory activity of antifungal preparations","volume":"36","author":"Rosen","year":"1997","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib63","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jaad.2020.09.055","article-title":"Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: a multicenter, double-blind, randomized controlled study","volume":"84","author":"Joly","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.11.007","article-title":"Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis","volume":"57","author":"Warshaw","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.082_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamadermatol.2023.0846","article-title":"Efficacy of roflumilast foam, 0.3%, in patients with seborrheic dermatitis: a double-blind, vehicle-controlled phase 2a randomized clinical trial","volume":"159","author":"Zirwas","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5826\/dpc.0603a04","article-title":"Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial","volume":"6","author":"Abbas","year":"2016","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jdv.12197","article-title":"Systematic review of oral treatments for seborrheic dermatitis","volume":"28","author":"Gupta","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.01.082_bib68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2019.02.002","article-title":"The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation","volume":"25","author":"Sparber","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011668","article-title":"\u03b3\u03b4 T cells respond directly and selectively to the skin commensal yeast Malassezia for IL-17-dependent fungal control","volume":"20","author":"Ruchti","year":"2024","journal-title":"PLoS Pathog"},{"issue":"10275","key":"10.1016\/j.jaad.2025.01.082_bib70","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.082_bib71","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.082_bib72","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jid.2018.03.1523","article-title":"The major orphan forms of ichthyosis are characterized by systemic T-cell activation and Th-17\/Tc-17\/Th-22\/Tc-22 polarization in blood","volume":"138","author":"Czarnowicki","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2025.01.082_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2016.03.025","article-title":"The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10","volume":"35","author":"Bros","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"28","key":"10.1016\/j.jaad.2025.01.082_bib75","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2174\/0929867324666170530093902","article-title":"Phosphodiesterase 4 inhibitors in immune-mediated diseases: mode of action, clinical applications, current and future perspectives","volume":"24","author":"Sakkas","year":"2017","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.082_bib77","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"515","key":"10.1016\/j.jaad.2025.01.082_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci Transl Med"},{"issue":"22","key":"10.1016\/j.jaad.2025.01.082_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131347","article-title":"Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy","volume":"4","author":"Chinthrajah","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jaad.2019.06.026","article-title":"Characterizing dupilumab facial redness: a multi-institution retrospective medical record review","volume":"82","author":"Waldman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.01.082_bib82","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/ccr3.2871","article-title":"Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: two case reports","volume":"8","author":"Al-Janabi","year":"2020","journal-title":"Clin Case Rep"},{"issue":"8","key":"10.1016\/j.jaad.2025.01.082_bib83","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/jid.2014.51","article-title":"IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models","volume":"134","author":"Nakajima","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.082_bib84","first-page":"31","article-title":"Hair and scalp disorders in adult and pediatric patients with skin of color","volume":"100","author":"Taylor","year":"2017","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.082_bib85","first-page":"466","article-title":"Top dermatologic conditions in patients of color: an analysis of nationally representative data","volume":"11","author":"Davis","year":"2012","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222500180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222500180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:03:29Z","timestamp":1777568609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222500180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S019096222500180X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.082","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}